Abbott Diabetes Care was created in 2004 with the acquisition of TheraSense Inc., a leading blood glucose monitoring business. The diagnostics portfolio was expanded with the addition of i-STAT ...

Earlier, in June 2024, the U.S. FDA cleared Abbott’s – Libre Rio and Lingo – new over-the-counter glucose monitoring devices. This should also aid the overall diabetes portfolio sales.

Participants in the campaign are invited to share their personal diabetes journeys with Glucerna, in order to gain the ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

The Precision Xtra Blood Glucose & Ketone Monitoring System was designed for easy testing. Intuitive setup and simple icon-driven menus help simplify blood glucose monitoring. In addition, the ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Tidepool, a software company committed to innovations in diabetes management, is thrilled ...

A new device from Abbott Laboratories, called Lingo, is geared toward people who don’t have diabetes but want to see how food and activity affect their glucose levels.

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Canadians living with type 2 diabetes agree that uplifting words, positive feedback and supportive tools are the most powerful motivators MISSISSAUGA, ON, Oct. 30, 2024 /CNW/ -- Abbott (NYSE ...

Shares of Abbott rose 2% in afternoon trade. Increasing diabetes care awareness, wider insurance coverage and preference for devices that do not need finger pricks have benefited CGMs such as ...

The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...

This positive outlook is driven by Abbott’s strategic positioning in high-growth areas such as Diabetes Care and Structural Heart markets, which make up a significant portion of its Medical ...